Pulmonary arterial hypertension leads to significant impairment in haemodynamics, right
heart function, exercise capacity, quality of life and survival. Current therapies have …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Pulmonary hypertension (PH) is a haemodynamic condition characterised by elevation of
mean pulmonary arterial pressure (mPAP)> 20 mmHg, assessed by right heart …

Exercise intolerance (EI) is the primary manifestation of chronic heart failure with preserved
ejection fraction (HFpEF), the most common form of heart failure among older individuals …

Background In pulmonary hypertension subgroups, elevated pulmonary vascular resistance
(PVR) of 3· 0 Wood units or more is associated with poor prognosis. However, the spectrum …

Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure≥ 25 mm Hg
at rest, measured during right heart catheterization. There is still insufficient evidence to add …

Survival in patients with pulmonary arterial hypertension (PAH) is closely related to right
ventricular (RV) function. Although pulmonary load is an important determinant of RV …

Pulmonary hypertension (PH) due to left heart disease, classified as group 2 according to
the Dana Point 2008 classification, is believed to be the most common cause of PH and is …

Right heart catheterisation (RHC) plays a central role in identifying pulmonary hypertension
(PH) disorders, and is required to definitively diagnose pulmonary arterial hypertension …